Oral anti-CD3 immunotherapy for HCV-nonresponders is safe,...

Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial

Halota, W., Ferenci, P., Kozielewicz, D., Dybowska, D., Lisovoder, N., Samira, S., Shalit, I., Ellis, R., Ilan, Y.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Journal of Viral Hepatitis
DOI:
10.1111/jvh.12369
Date:
August, 2015
File:
PDF, 127 KB
english, 2015
Conversion to is in progress
Conversion to is failed